The company earlier announced that the primary endpoint was met in a randomized, double-blind, placebo-controlled Phase IIb ...

I-Mab has laid off almost a third of its employees as part of a restructuring effort, the company disclosed in a recent ...

Chinese biotech company Vigonvita Life Sciences has filed for an initial public offering (IPO) on the Hong Kong Stock ...

US mRNA specialist Moderna demonstrated substantial R&D investment and progress in the UK, two years since signing its ...

The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

Fondazione Telethon, an Italian biomedical charity focused on rare genetic diseases, has submitted a Marketing Authorization ...

Russia plans to significantly expand the geography of the export of its drugs this year, paying attention both to emerging ...

California-based ImmunityBio has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (to be ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

At Sweden’s annual life science conference, stakeholders from healthcare, academia, and industry discussed implementing the ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a ...